Skip to content

Effect of rimazolam besylate on hemodynamics of anesthesia induction and maintenance in patients undergoing abdominal surgery

Effect of rimazolam besylate on hemodynamics of anesthesia induction and maintenance in patients undergoing abdominal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055946
Enrollment
Unknown
Registered
2022-01-28
Start date
2022-03-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac disease

Interventions

The control group:Propofol as induction agent
0.1mg/kg/min remazolam benzenesulfonic group:0.1mg/kg/min remazolam benzenesulfonic as induction agent
0.2mg/kg/min remazolam benzenesulfonic group:0.2mg/kg/min remazolam benzenesulfonic as induction agent

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years, regardless of gender; 2. Patients undergoing elective abdominal surgery under general anesthesia; 3. ASA score = 3 days.

Exclusion criteria

Exclusion criteria: 1. Time of emergency surgery or elective surgery = 160mmHg and/or diastolic blood pressure >= 100 mmHg); 4. Abnormal laboratory tests (anemia: Hb = 2.5xULN, TBIL >= 1.5xULN; Abnormal renal function, blood creatinine greater than the normal upper limit); 5. Acute angle-closure glaucoma, myasthenia gravis, acute alcoholism; 6. Patients with shock (systolic blood pressure <= 90mmHg) or coma; 7. Patients with allergy or drug resistance to benzodiazepines; 8. Pregnant or breast-feeding women; 9. Need to use cardiopulmonary bypass, hepatectomy or liver transplantation; 10. Participated in clinical trials of other drugs as a subject within the last 3 months; 11. The patient was deemed unsuitable to participate in the study by the researcher or refused by the patient himself.

Design outcomes

Primary

MeasureTime frame
Cardiac Index;

Secondary

MeasureTime frame
Sedation score (MOAA/SS score);Depth of anesthesia (BIS value);Analgesic intensity (Pain stress index);mean arterial pressure, MAP;Myocardial systolic index;Stroke volume index;systemic vascular resistance index;Sedation time;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactBai Yiping

The Affiliated Hospital of Southwest Medical University

baiyiping0608@163.com+86 18982797213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026